mediXeed – Your medical CPD/CME partner of choice in South Africa

Current Status
Not Enrolled
Get Started
This activity is currently closed


The older Type 1 and Type 2 Diabetic patients: how clinicians can be 'older and wiser' also

The needs of older diabetic patients change over time. In this discussion, Dr Zane Stevens provides practical advice for the busy clinician who is concerned about his elderly Type 1 and Type 2 diabetic patients.

About our experts

Dr Zane Stevens
Adult Endocrinologist

Christiaan Barnard Memorial Hospital, Cape Town MBChB cum laude, MMED, FCP (SA),
Fellowship in Endocrinology & Metabolism

Dr Zane Stevens is an Endocrinologist at the Cape Institute of Endocrinology, Cape Town, with expertise in diabetes, thyroid disease, and osteoporosis. He's contributed to medical guidelines, co-authoring chapters in SEMDSA guidelines and the Tropical Handbook of Medicine.

Dr Stevens is actively involved in training, serving as an examiner for Endocrinology & Metabolism. He's also a founding member of the Cape Thyroid Forum MDT and speaks regularly at CME events.

Dr Brad Merwitz
Physician & Endocrinologist

Wits Donald Gordon Medical Centre
Netcare Milpark Hospital

Dr Brad Merwitz is a specialist physician and endocrinologist with a special interest in diabetes mellitus (especially Type 2), osteoporosis, cardiovascular risk management, lipidology and general endocrinology. In addition, Dr Merwitz has an interest in novel approaches to metabolic well-being including exercise strategies, intermittent fasting and cold exposure.

Since March 2017 Dr Merwitz has been working as an endocrinologist in private practice at Netcare Milpark Hospital and the Mediclinic Wits Donald Gordon Medical Centre.

Learning objectives

This accredited discussion by expert endocrinologists aims:

  • to provide clinicians who are aware of the changing needs of their elderly diabetic patients, with best practice advice on the most effective treatment options for these patients.
  • The clinical trial evidence supporting the development of the 2023 EASD guidelines on diabetes treatment for the elderly will be explained and applied to our circumstances to optimise care of elderly Type 1 and Type 2 diabetic patients in the country.